ID: ALA5180506

Max Phase: Preclinical

Molecular Formula: C16H19N

Molecular Weight: 225.33

Representations

Canonical SMILES:  [2H]C12CC3c4ccccc4C4CC(N)(C1)CC34C2

Standard InChI:  InChI=1S/C16H19N/c17-15-6-10-5-13-11-3-1-2-4-12(11)14(8-15)16(13,7-10)9-15/h1-4,10,13-14H,5-9,17H2/i10D

Standard InChI Key:  JTGSYLMMWSVQGE-MMIHMFRQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 225.33

Molecular Weight (Monoisotopic): 225.1517

AlogP: 3.16

#Rotatable Bonds: 0

Polar Surface Area: 26.02

Molecular Species: BASE

HBA: 1

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 1

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 10.54

CX LogP: 2.35

CX LogD: -0.44

Aromatic Rings: 1

Heavy Atoms: 17

QED Weighted: 0.72

Np Likeness Score: 0.80

References

1. Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S..  (2022)  Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.,  236  [PMID:35453065] [10.1016/j.ejmech.2022.114354]

Source

Source(1):

• Scientific Literature